Glucose Transporter (GLUT-4) Is Targeted to Secretory Granules in Rat Atrial Cardiomyocytes by Slot, Jan W. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/97/06/1243/12 $2.00
The Journal of Cell Biology, Volume 137, Number 6, June 16, 1997 1243–1254 1243
 
Glucose Transporter (GLUT-4) Is Targeted to Secretory
Granules in Rat Atrial Cardiomyocytes
 
Jan W. Slot,*
 
‡
 
 Gabriella Garruti,*
 
¶
 
 Sally Martin,
 
‡
 
 Viola Oorschot,* George Posthuma,*
Edward W. Kraegen,
 
§
 
 Ross Laybutt,
 
§
 
 Gaétan Thibault,
 
i 
 
and David E. James
 
‡
 
*Department of Cell Biology, Medical School, Utrecht University, 3584 CX Utrecht, The Netherlands; 
 
‡
 
Centre for Molecular 
and Cellular Biology, University of Queensland, St. Lucia, QLD, 4072, Australia; 
 
§
 
Garvan Institute of Medical Research, St. 
Vincents Hospital, Darlinghurst, NSW, 2010, Australia; 
 
i
 
Cell Biology of Hypertension, Clinical Research Institute of Montreal, 
 
Montreal, Quebec, H2W 1R7, Canada; and 
 
¶
 
Endocrinology and Metabolic Diseases, Institute of Medicine, University of Bari, 
70124 Bari, Italy
 
Abstract. 
 
The insulin-responsive glucose transporter 
GLUT-4 is found in muscle and fat cells in the 
 
trans
 
-
Golgi reticulum (TGR) and in an intracellular tubulo-
vesicular compartment, from where it undergoes insulin-
dependent movement to the cell surface. To examine 
the relationship between these GLUT-4–containing 
compartments and the regulated secretory pathway we 
have localized GLUT-4 in atrial cardiomyocytes. This 
cell type secretes an antihypertensive hormone, re-
ferred to as the atrial natriuretic factor (ANF), in re-
sponse to elevated blood pressure. We show that 
GLUT-4 is targeted in the atrial cell to the TGR and a 
tubulo-vesicular compartment, which is morphologi-
cally and functionally indistinguishable from the intra-
cellular GLUT-4 compartment found in other types of 
myocytes and in fat cells, and in addition to the ANF 
secretory granules. Forming ANF granules are present 
throughout all Golgi cisternae but only become GLUT-
4 positive in the TGR. The inability of cyclohexamide 
treatment to effect the TGR localization of GLUT-4 in-
dicates that GLUT-4 enters the ANF secretory gran-
ules at the TGR via the recycling pathway and not via 
the biosynthetic pathway. These data suggest that a 
large proportion of GLUT-4 must recycle via the TGR 
in insulin-sensitive cells. It will be important to deter-
mine if this is the pathway by which the insulin-regulat-
able tubulo-vesicular compartment is formed.
 
G
 
lucose
 
 entry into mammalian cells occurs in most
cases by facilitative transport, a process that is me-
diated by a family of glucose transporter proteins.
The individual members of this family, GLUTs 1–7, are
variably expressed in different tissues (Bell et al., 1993).
GLUT-4 is expressed in cell types, such as skeletal muscle,
cardiac muscle, white and brown adipose tissue, that ex-
hibit acute changes in glucose transport (Birnbaum, 1989;
James et al., 1989). Most glucose transporter isoforms con-
stitutively reside at the cell surface to optimize exposure of
the cell to the extracellular glucose (James and Piper,
1994). In contrast, GLUT-4 is found in an intracellular
compartment from where it can be rapidly translocated to
the cell surface in response to insulin, thus allowing the
cell to transiently increase its access to extracellular glu-
cose (Cushman and Wardzala, 1980; Suzuki and Kono, 1980).
This process plays an important role in the postabsorptive
removal of glucose from the bloodstream in mammals and
also during enhanced energy consumption, such as exer-
cise in the case of muscle.
Despite considerable progress in our understanding of
insulin-regulated GLUT-4 movement, the nature of the in-
tracellular GLUT-4 storage compartment, and the intra-
cellular trafficking pathway(s) undertaken by GLUT-4,
remain to be fully defined. Morphological studies have
provided important clues concerning GLUT-4 trafficking
in insulin-sensitive cells (Slot et al., 1991
 
a
 
,
 
b
 
; James et al.,
1994). GLUT-4, like a number of other cell surface recy-
cling proteins, is internalized from the cell surface via
clathrin-coated pits (Robinson et al., 1992). Thereafter,
the transporter is sorted from the lysosomal pathway into
a compartment comprising tubules and vesicles that we
have referred to as tubulo-vesicular (T-V)
 
1
 
 elements. The
relationship of this compartment to other secretory com-
partments is currently not known. It has been suggested
that it has specialized properties that distinguish it from
the endosomal/
 
trans
 
-Glogi reticulum (TGR) system (Mar-
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cose; TGR, 
 
trans
 
-Golgi reticulum; T-V, tubulo-vesicular.
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tin at al., 1994; Herman et al., 1994). However, it is not
clear if it arises like small synaptic vesicles from the endo-
somal system, or like secretory granules from the biosyn-
thetic pathway (Rindler, 1992). One way to address this is-
sue is to study the trafficking of GLUT-4 in a cell type that
possesses one or more of these secretory systems. GLUT-4
has been expressed in PC12 cells, a neuroendocrine cell
line that contains two regulated secretory systems: small
synaptic vesicles, which evolve from endosomes, and
dense core granules, which are formed in the biosynthetic
pathway. In one study (Hudson et al., 1993), a small pro-
portion (
 
z
 
14%) of GLUT-4 was targeted to dense core
granules with the remainder being found in T-V elements
distinct from synaptic vesicles. In contrast, Herman et al.
(1994) did not detect GLUT-4 in dense core granules, the
majority being found in a small, vesicular compartment
distinct from synaptic vesicles or recycling endosomes.
In an effort to further explore this question we have
studied a bona fide regulated secretory cell type, atrial myo-
cytes, in which GLUT-4 is endogenously expressed. The
main secretory product of the atrial cardiomyocyte is the
precursor of atrial natriuretic factor (ANF), an antihyper-
tensive hormone (De Bold, 1985; Ruskoaho, 1992). In the
present study we have shown that GLUT-4 is expressed at
high levels in atrial cardiomyocytes. This presented the op-
portunity to study the distribution of GLUT-4 in a cell
type that contains both an insulin-regulatable transport
system and a regulated secretory pathway. Our data show
that a large proportion of GLUT-4 (50–60%) is targeted
to the ANF-containing secretory granules. GLUT-4 ap-
pears to enter this compartment as it recycles through the
TGR and so we suggest that this may represent an impor-
tant and unique aspect of the function of this molecule.
 
Materials and Methods
 
Materials
 
Polyclonal rabbit antiserum against the cytoplasmic carboxy terminus of
GLUT-4 (James et al., 1989) has been described previously. Rabbit antisera
against the NH
 
2
 
 and COOH termini of the pro-ANF polypeptide were
used. Since only the prohormone of ANF could be detected in the myo-
cytes the immunolabeling pattern for both antisera was similar (Cantin et
al., 1990). This is referred to as ANF labeling. Rabbit anti–gamma adaptin
antibodies were kindly provided by Margaret Robinson, Cambridge Uni-
versity, UK. Goat anti–rabbit IgG conjugated to CY3 was obtained from
Jackson ImmunoResearch Laboratories, West Grove, PA. HRP-conju-
gated goat anti–rabbit IgG and enhanced chemiluminescence (ECL) de-
tection kits were from Amersham (Aylesbury, UK). Colloidal gold was
prepared by tannic acid-citrate reduction (Slot and Geuze, 1985) and cou-
pled to protein A (Roth et al., 1978; Slot et al., 1988).
 
Immunocytochemistry
 
Male Wistar rats were fasted overnight, unless indicated otherwise. Stimu-
lated animals were injected intraperitoneally with a mixture of insulin (8
U/kg) and 
 
d
 
-glucose (1 g/kg) 30 min before fixation. Whole body fixation
was performed on animals that were anesthetized with pentobarbitone as
described (Slot et al., 1991
 
a
 
), using a mixture of 2% paraformaldehyde
and 0.2% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4. In
some experiments glutaraldehyde was omitted or fresh atrial tissue was
dissected and fixed by immersion. For cryosectioning (Slot et al., 1991
 
a
 
)
small fragments of the fixed tissue were prepared from the rim of the left
or right atrium and immersed in 10% gelatin for 
 
z
 
15 min at 37
 
8
 
C. The gel-
atin was then solidified on ice and small gelatin-embedded tissue blocks
were immersed in 2.3 M sucrose at 4
 
8
 
C overnight. Tissue blocks from the
left ventricle were processed similarly to the atrial tissue. Liver tissue
blocks were prepared without gelatin. Omission of the gelatin-embedding
step resulted in serious damage to the myocyte ultrastructure, probably
due to overstretching of the sections when they were thawed on sucrose
(Liou et al., 1996). On the other hand, this overstretching resulted in in-
creased accessibility of the antigens as the immunolabeling efficiency was
generally higher in these sections. Thus, in some experiments the gelatin
embedding of heart tissue was omitted to take advantage of this increased
labeling efficiency. For light microscopy (LM), 
 
z
 
300-nm-thick cryosec-
tions were cut at 
 
2
 
90
 
8
 
C, and for EM, 50–70-nm sections were cut at
 
2
 
120
 
8
 
C using an Ultracut S/FCS (Leica Inc., Vienna, Austria) equipped
with an antistatic device (Diatome, Biel, Switzerland) and a diamond
knife (Drukker, Cuyck, The Netherlands). The EM sections were immu-
nolabeled using protein A–gold as the marker for single and double label-
ing (Slot et al., 1991
 
a
 
). LM sections were placed on poly-
 
l
 
-lysine–coated
glass slides and similarly immunolabeled, using CY3-conjugated goat
anti–rabbit IgG as a fluorescent marker.
 
Immunoblotting
 
Different regions of the heart were dissected from rats and frozen at
 
2
 
80
 
8
 
C. Frozen tissue was thawed into ice-cold PBS containing protease
inhibitors (10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml aprotinin, 250 
 
m
 
M phenyl-
methane sulphonylfluoride), washed free of blood and homogenized thor-
oughly in the same buffer (1 ml) first using a polytron homogenizer and
then by passage through a 22-gauge needle (Polytron; Brinkmann Instru-
ments, Westbury, NY). Aliquots of the homogenate were removed and
solubilized for 1 h in 1% Triton X-100 (final concentration) at 4
 
8
 
C. The in-
soluble material was pelleted for 10 min in a microfuge (Sorvall, Wilming-
ton, DE) and the supernatant retained for immunoblotting. The protein
concentration of the homogenates and the solubilized extracts was deter-
mined using the BCA reagent (Pierce Chemical Co., Rockford, IL).
Equal amounts of protein (25 
 
m
 
g) were separated by SDS-PAGE using
a 10% acrylamide resolving gel. Proteins resolved by SDS-PAGE were
electrophoretically transferred to nitrocellulose. Nitrocellulose sheets
were incubated with the polyclonal antibodies diluted 1/1,000 (vol/vol) in
1% dried milk in PBS, pH 7.4. Detection of immunoreactive bands was
achieved using ECL and quantitation was performed using an imaging
densitometer (GS-670; Bio-Rad Laboratories, Richmond, CA) and the
molecular analyst program.
 
[
 
3
 
H]-2-Deoxyglucose Uptake
 
Male Wistar rats were fitted with cannulae introduced into the carotid ar-
tery and jugular vein as previously described (Kraegen et al., 1985). Car-
diac glucose uptake was assessed 7 d after surgery. Basal studies or eugly-
cemic hyperinsulinemic clamps were performed after a 24-h fast as
described previously (Kraegen et al., 1985). Briefly, insulin (Actrapid-HM
Neutral; Novo Nordisk, Bagsvaerd, Denmark) was infused via the carotid
cannula, at 0.25 U/kg/h for 2 h while the blood glucose concentration was
maintained at basal fasting levels by a variable rate glucose infusion (dex-
trose 30 g/100 ml; Astra Pharmaceuticals, North Ryde, NSW, Australia).
At steady-state euglycemia (
 
z
 
75 min after commencement of the
clamp or 2 min after intravenous saline injection), an intravenous bolus of
[
 
3
 
H]-2-deoxyglucose (80 
 
m
 
Ci) (
 
3
 
H-2DG) (Amersham) was administered.
Blood samples (200 
 
m
 
l) were obtained after administration of the bolus
for estimation of plasma tracer and glucose concentration. Plasma samples
for determination of tracer concentration were deproteinized immediately
in 5.5% ZnSO
 
4
 
 and saturated Ba(OH)
 
2
 
. At completion of the study (45
min after 
 
3
 
H-2DG administration), rats were anesthetized (pentobarbi-
tone; 60 mg/kg, intravenously) and the right and left atria and ventricles
were rapidly removed and frozen. An estimate of tissue glucose uptake
(the glucose metabolic index, Rg’) was calculated from the tissue accumu-
lation of phosphorylated 
 
3
 
H-2DG (Kraegen et al., 1985).
 
Plasma ANF Determinations
 
To assess the effect of insulin on ANF secretion, the plasma level of the
NH
 
2
 
-terminal fragment (1–98) of pro-ANF was determined 10 min before
and 10, 40, and 70 min after commencement of the euglycemic hyperin-
sulinemic clamp in 24-h fasted rats by radioimmunoassay as described pre-
viously (Thibault et al., 1988). The NH
 
2
 
-terminal fragment, being cose-
creted with ANF in the blood, reflects the secretory function of the atria
(Itoh et al., 1988). The major advantage of measuring the NH
 
2
 
-terminal
fragment rather than ANF is that the former requires less plasma (0.1 ml vs
2.0 ml), allowing multiple samples to be obtained from the same animal. 
Slot et al. 
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Figure 1. Distribution of ANF and GLUT-4 in cardiac tissues. (A) Fluorescence distribution of ANF in the right atrium. Most of the la-
beling was observed in small punctate dots that seemed to accumulate in a juxta-nuclear (n) position (arrowheads). (B) Distribution of
GLUT-4 in right atrium. As well as positive dots that resemble the ANF labeling pattern, GLUT-4 reactivity was also found in a fine
granular pattern that displays a periodicity in places where the cells are cut longitudinally. In the GLUT-4 staining pattern of the left ven-
tricle (C), the fine granular staining is more predominant and clearly follows the sarcomeric periodicity. At some places it seemed to fol-
low the plasma membrane (arrrowheads) or other longitudinal lines (arrows). Concentrations of GLUT-4 were occasionally observed
near the nucleus (n) but these were less significant than in the atrium. Bars, 10 mm. (D) Immunoblots of GLUT-4 from tissue samples of
right atrium (RA), left atrium (LA), right ventricle (RV), and left ventricle (LV). The results are from two experiments (a and b) in each
of which equivalent samples from three rats were pooled. The optical density of the GLUT-4 reaction, underneath the bands of each tis-
sue, is given as the average of the two experiments in percentages of the value measured for the right atrium. 
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Figure 2. Immuno-EM images of GLUT-4 and ANF labeling in atrial myocytes. (A) Immunogold labeling of a cryosection of the right
atrium for ANF (10 nm gold). Most gold is in the spherical secretory granules (s). Similar labeling is also associated with smaller struc-
tures (see center part of image), which are presumably forming granules. The profile of one of these (arrow) suggests its connection to
the Golgi cisternae (g). Some disperse labeling of the Golgi cisternae is present as well. (B) GLUT-4 labeling of a section taken from
right atrial tissue that was not embedded in gelatin (see Materials and Methods). Such sections became overstretched during thawing
(Liou and Slot, 1996), which resulted in considerable structural damage, but also a more efficient labeling due to better penetration con-
ditions for the immunoreagents. GLUT-4 labeling is clear around all of the secretory granules. m, mitochondria; n, nucleus. C, as B, but
this section is from gelatin-embedded tissue. GLUT-4 labeling (10 nm gold) is clearly associated with the secretory granule membranes.
Forming granules (arrows) attached to Golgi cisternae (g) occasionally show GLUT-4 labeling (left), but this was rare (right; see also
Fig. 4). The Golgi stacks at the right are negative for GLUT-4, but GLUT-4 is clearly present at the trans side of the stacks at the left.
Bars, 200 nm. 
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Results
 
In the present study our primary goal was to characterize
the intracellular GLUT-4 compartment. Therefore, most
of the localization studies were performed in atrial myo-
cytes of nonstimulated, overnight-fasted animals.
 
Immunofluorescence Microscopy
 
The alignment of myocytes in atrial tissue (Fig. 1, 
 
A
 
 and
 
B
 
) is ordered in a much more complicated fashion than in
the ventricle (Fig. 1 
 
C
 
), and so the atrial fibers are sec-
tioned much more randomly. Ventricular cells were viewed
in longitudinally cut sections. We observed no significant
difference in ANF or GLUT-4 labeling between the right
and left atrium. As reported previously (Cantin et al., 1990;
Thibault et al., 1989), the localization of ANF was re-
stricted to secretory granules which appear by LM as dots
scattered throughout the cells, but primarily concentrated
near the nucleus (Fig. 1 
 
A
 
). The labeling pattern observed
for GLUT-4 in the atrium was more complex (Fig. 1 
 
B
 
).
GLUT-4 labeling, like that of ANF, occurred in large
punctate structures both in the perinuclear region and
elsewhere. However, beyond the perinuclear region very
fine granular structures were predominantly labeled for
GLUT-4. In longitudinal-sectioned myocytes these ap-
peared arranged parallel to the cross-striation of the myo-
fibers. In the ventricle a similar grainy labeling pattern is
evident for GLUT-4, again with clear cross arrangement
with a periodicity similar to the sarcomeres (Fig. 1 
 
C
 
). In
addition, some arrangement in the longitudinal direction
was apparent, the dots either following the cell surface or
the spaces between the myofibrils (Fig. 1 
 
C
 
). Previously,
we observed that this fine granular labeling is due to small
T-V elements that occur predominantly at the Z-line level
in cardiomyocytes (Slot et al., 1991
 
b
 
). Typically, the
GLUT-4 labeling pattern in the atrium, at the level of LM,
resembled a composite image of atrial ANF labeling and
ventricular GLUT-4 labeling.
 
Expression of GLUT-4 in Heart
 
The immunofluorescence signal for GLUT-4 was consis-
tently stronger in atrium than in ventricle. This was con-
firmed by immunoblotting (Fig. 1 
 
D
 
), which indicated a
higher expression of GLUT-4 in atrial tissue. When ex-
pressed per unit of protein, the immunoreactivity for
GLUT-4 was approximately two times higher in the left
and right atrium than in either ventricle.
 
Immuno-EM of ANF
 
The ANF localization observed in the present study was
similar to that described previously (Thibault et al., 1989;
Cantin et al., 1990). Most of the labeling occurred in secre-
tory granules (Fig. 2 
 
A
 
). Forming granules in the Golgi
complex were smaller than the secretory granules and
were labeled with similar intensity. Besides the forming
granules there was also some disperse labeling in the Golgi
cisternae. In general, ANF labeling in both of these loca-
tions was more exaggerated in tissues from animals fed ad
lib. However, labeling of the Golgi complex was rather
variable between individual animals and cells. Diffuse la-
beling was often more obvious in the cisternae at the 
 
cis
 
side of the Golgi stack (Fig. 4 
 
E
 
).
 
Immuno-EM of GLUT-4
 
A significant proportion of the total GLUT-4 labeling (50–
60%) was found in ANF secretory granules (Table I) in
regular sections. In overstretched sections, where GLUT-4
labeling was enhanced (Fig. 2 
 
B
 
), virtually all secretory
granules were labeled for GLUT-4, whether they were in
the Golgi area or toward the cell periphery. The secretory
granules of the atrial myocyte are unusual in that their
membrane is often coated (Jamieson and Palade, 1964;
Newman and Severs, 1992). In the cryosections these coats
appeared as fuzzy layers, which were most clear in the
overstretched sections of tissue fixed without glutaralde-
hyde (Fig. 3). The coats were present on granules in the
perinuclear (Fig. 3 
 
A
 
) as well as in the peripheral (Fig. 3 
 
B
 
)
regions of the cell. These coats were labeled with antibod-
ies specific for both clathrin (data not shown) and for AP1,
the gamma adaptor protein (Fig. 3 
 
C
 
). The density of
GLUT-4 labeling was similar within coated and noncoated
regions of the granules (Fig. 3, 
 
A
 
 and 
 
B
 
). Apart from the
granule labeling, the distribution of GLUT-4 within the
atrial myocyte was similar to that reported previously in
ventricular myocytes (Slot et al., 1991
 
b
 
). Small GLUT-4–
positive T-V elements were scattered throughout the cells,
often associated with the Z-line zones. These probably
cause the cross-striated pattern in the fluorescence obser-
vations (Fig. 1, 
 
B
 
 and 
 
C
 
). These structures, with which
 
z
 
30% of the GLUT-4 labeling was associated (Table I),
were morphologically indistinguishable from the GLUT-
4–containing T-V elements in the ventricle myocytes (Slot
et al., 1991b). Labeling of similar vesicles and tubules was
often observed at the 
 
trans
 
 side of the Golgi complex in
the atrial cell (Fig. 4, 
 
A, C, and D). These we considered as
part of the TGR.
The structure of the Golgi complex in the rat atrial cell
has been studied in detail by Rambourg and colleagues
(1984). They described the entire structure as a continuum
of plate-shaped stacks of cisternae that are interconnected
by tubular regions in such a way that they form a beltlike
structure around the nucleus. This belt is complicated by
the formation of loops at both nuclear poles. A character-
istic stack comprises five cisternae. Each cisterna has spe-
cific morphological and cytochemical features. In the peri-
nuclear stacks the first or cis-most cisternae always faces
Table I. Relative Distribution of GLUT-4 Gold Particles in 
Myocytes of the Right Atrium of Overnight-fasted Rats
Region Gold labeling
Plasma membrane ,1
Golgi 1 TGR 13.8 6 1.7
T-V elements 31.0 6 0.3
ANF granules 54.9 6 1.7
The plasma membrane includes only the cell surface membrane. Transverse tubules,
where detectable, were usually unlabeled, indicating that the proportion of gold asso-
ciated with these structures was negligible. TGR and Golgi cisternae have been com-
bined because they could not always be distinguished. Each value represents the mean 6
SEM of three separate experiments. For each experiment at least 500 gold particles
were quantified. The labeling over the nucleus, myofilaments, mitochondria, and cy-
toplasm was very low (,0.3 gold/mm) and considered nonspecific. Thus, this has not
been included in these analyses.The Journal of Cell Biology, Volume 137, 1997 1248
the nucleus, which facilitates the recognition of the cis–
trans orientation, making the use of specific markers for
either side unnecessary. The fifth cisterna, which is often
partly detached from the stack, probably represents part
of the TGR as defined by Griffiths and Simons (1986).
Rambourg and colleagues also focused on the biogenesis
of ANF-secretory granules in the atrial myocyte. They
found forming granules attached to all, except the cis-most,
Golgi cisternae. The attachment is preferentially via tubu-
lar extensions, which explains why such connections are
rarely seen in thin sections (Fig. 2 A). We found GLUT-4
labeling in the TGR (Fig. 4, A, C, and D) and sometimes
in the trans-most cisternae of the Golgi stack (Fig. 4, B and
E) but not in the medial and cis cisternae. Forming secre-
tory granules in the trans-Golgi were often labeled for
GLUT-4 (Fig. 2 C), but this was not the case for ANF-pos-
itive granules that were connected to the medial or cis cis-
ternae of the Golgi stack (Fig. 4, A, C, D, and E). In non-
stimulated cells there was no detectable (,1%) GLUT-4
labeling at the cell surface (Table I). The internal plasma
membrane of the transverse tubules was excluded from
the counting since these structures could not always be
recognized in the sections. However, distinct transverse
tubule profiles were usually not labeled for GLUT-4.
Effects of Cyclohexamide Treatment
To determine if GLUT-4 within the trans-Golgi originated
from the biosynthetic pathway or the recycling pathway,
we performed experiments using the protein synthesis in-
hibitor cyclohexamide. To test the efficacy of the cyclo-
hexamide treatment we first examined its effects on albu-
min labeling in liver. After 1 h of cyclohexamide treatment
there was a substantial reduction in liver albumin labeling
(compare Fig. 5, A and B). Longer periods of cyclohexamide
treatment (2 h) did not further change this situation. Simi-
Figure 3. Clathrin coats on ANF granules. Sections of atrial tissue
fixed without glutaraldehyde and not embedded in gelatin. (A and B)
Sections treated as in Fig. 2 B. Coated parts can be seen on granules
(arrows), in A, in the cell center (g, Golgi complex) and, in B, near the
cell surface (ex, extracellular space). GLUT-4 labeling (10 nm gold) is
similar in coated segments and other parts of the granule surface. (C)
Section labeled for the TGR-type adaptor protein, AP1. Coats on
ANF granules are labeled (10 nm gold) for AP1 (arrows). n, nucleus.
Bars, 200 nm.Slot et al. GLUT-4 in Atrial Natriuretic Factor Granules 1249
Figure 4. Immuno-EM of ANF and GLUT-4 labeling in the Golgi region of atrial myocytes. Cryosections are double labeled for GLUT-4
(10 nm) and ANF (5 nm). A and B are from overnight-fasted rats, whereas C–E are from rats fed ad lib. Disperse labeling of the Golgi
cisternae (g) for ANF is sometimes almost absent (A and B), sometimes low (C and D), and occasionally quite abundant (E). In the lat-
ter case, disperse ANF labeling seemed to be present mainly in the cis cisternae of the Golgi. The cis side of the Golgi faces the nucleus
(n). GLUT-4 labeling is present in trans-Golgi elements (arrowheads in A, C, and D). In B and more clearly in E, one or two cisternae at
the trans side of the Golgi stack are labeled for GLUT-4. Secretory granules show solid ANF and peripheral GLUT-4 labeling, but
ANF-positive forming granules (arrows), which are attached to the first (D), second (E), and third (A and C) cisternae from the cis side,
are GLUT-4 negative. f, myofibrils; z, Z-line. Bars, 200 nm.The Journal of Cell Biology, Volume 137, 1997 1250
larly, in atrial cardiomyocytes from the same animals
cyclohexamide treatment completely abolished the pres-
ence of newly forming granules in the Golgi cisternae.
Also the disperse labeling for ANF in the cisternae that we
observed in control cells was virtually absent (Fig. 5 C).
These data indicate that the cyclohexamide treatment ef-
fectively blocked protein synthesis in the atrial myocytes.
Despite this, GLUT-4 labeling at the trans side of the
Golgi was not affected by cyclohexamide treatment, indi-
cating that GLUT-4 at this location is not derived from the
biosynthetic pathway.
Insulin Stimulation
We have previously shown that insulin stimulates the
movement of GLUT-4 from the T-V elements and TGR to
the cell surface in other insulin-sensitive cells (Slot at al.,
1991a; James et al., 1994). In the present study it was of
considerable interest to examine the effects of insulin on
exocytosis of the GLUT-4/ANF-containing granules in
atrial myocytes. Insulin caused a significant increase in
GLUT-4 labeling all along the plasma membrane in atrial
cardiomyocytes. However, this effect was less than that
observed in ventricular cells. In five measurements from
longitudinally cut cells from left ventricle and right atrium
of the same animals, we observed 0.96 6 0.03 and 0.41 6
0.06 gold particles per micrometer of plasma membrane,
respectively. In basal myocytes of ventricle as well as
atrium, GLUT-4 labeling of the plasma membrane was at
undetectable low level (Table I).
To further confirm the response to insulin in atrium we
next examined the effect of insulin on 2-deoxyglucose
Figure 5. Effects of cyclohexamide on ANF and GLUT-4 labeling. Cryosections are from rats fed ad lib. (A and B) Liver sections im-
munolabeled for rat serum albumin (10 nm gold). (C) Right atrium, double labeled for GLUT-4 (10 nm gold) and ANF (5 nm gold). A
is from a control rat; B and C are from a rat treated for 1 h with cyclohexamide. In normal rat liver, albumin marks the biosynthetic
secretory route, with diffuse labeling in the RER (r) and dense labeling in Golgi cisternae and secretory vesicles (v). After cyclohexamide
treatment albumin is much less present in these compartments and secretory vesicles are not seen. In atrial myocytes (C) of the same rat
as in B, Golgi cisternae (g) are devoid of diffuse ANF labeling and ANF-positive forming granules are rarely seen. GLUT-4 labeling is
still associated with elements at the trans side of the Golgi stack (arrowheads) and with the trans-most cisterna (arrow) like in control an-
imals (Fig. 4). n, nucleus. Bars, 200 nm.Slot et al. GLUT-4 in Atrial Natriuretic Factor Granules 1251
(2DG) uptake in different heart regions using the hyperin-
sulinemic euglycemic clamp technique in whole animals
(Table II). This technique enables measurement of 2DG
uptake, an estimate of glucose transport, in individual tis-
sues of the rat in vivo after the infusion of insulin and vari-
able amounts of glucose to prevent the onset of hypoglyce-
mia (Kraegen et al., 1985). The basal 2DG uptake rate was
very low, consistent with the predominant intracellular
distribution of GLUT-4 observed by EM under these con-
ditions (Table I; Slot et al., 1991b). In addition, there was
no significant difference in 2DG uptake among the various
heart regions in basal animals. Insulin caused a substantial
increase in 2DG uptake in both atrium and ventricle.
However, quantitatively the effect was significantly lower
in the atrium than in the ventricle, once again consistent
with the EM observations. Together with the observation
that GLUT-4 expression is twofold higher in atrial tissue
(Fig. 1 D), this suggests that insulin-induced translocation
of the transporter is less efficient there (we estimate five to
eight times) than in the ventricular myocyte. Indeed, ini-
tial immunocytochemical observations indicated that the
GLUT-4 labeling that could be measured at the cell sur-
face after insulin stimulation represented no more than
2–4% of the total cellular labeling (data not shown). This
seems rather low when compared with the z25% surface
labeling that we found previously in stimulated ventricular
myocytes, but that was in response to a maximal stimula-
tion involving both insulin and exercise. Taking that into
account together with the five to eight times lower re-
sponse of the atrial cell to insulin, one cannot expect more
than a few percent GLUT-4 labeling at the cell surface af-
ter insulin treatment. Such minor changes were too incon-
spicuous for establishing immunocytochemically to what
extent each of the intracellular pools (T-V elements; TGR;
ANF granules) contributed to the translocation of GLUT-4.
For that reason we did not pursue such studies in insulin-
stimulated atrium.
We also explored if insulin treatment had an effect on
ANF secretion which could imply a certain participation
of the secretory granule-associated GLUT-4 pool in insu-
lin-dependent GLUT-4 translocation. However, we could
not detect a significant effect of insulin on ANF secretion
in the rat. There was no substantial difference in the
amount of the prohormone detected by immunoblotting in
homogenates of atrial tissue, obtained from nonstimulated
and insulin-treated (30 min) animals (data not shown).
Furthermore, the serum concentration of NH2-terminal
ANF, which reflects the atrial secretory fraction (Itoh et
al., 1988), was measured. Severalfold raises of serum con-
centration of ANF have been reported after appropriate
stimuli of ANF release (Horky et al., 1985; Manning et al.,
1985; Lang et al., 1985), which are mostly related to atrial
stretch the major stimulator of ANF secretion (Ruskoaho,
1992). No detectable changes in serum levels of ANF
could be detected after insulin stimulation (Table III).
Discussion
In muscle and adipose tissue, GLUT-4 is localized to an in-
tracellular compartment comprising small tubules and ves-
icles clustered in the vicinity of the endosomal/TGR sys-
tem (Slot et al., 1991a,b; Rodnick et al., 1992; James et al.,
1994). Despite partial overlap with recycling endosomes
and the TGR (Hanpeter and James, 1995; Livingstone et
al., 1996; Martin et al., 1996) a large proportion of intracel-
lular GLUT-4 appears to be segregated into a population
of vesicles that contain the neuronal v-SNARE, VAMP-2,
and an amino peptidase, vp165 (Cain et al., 1992; Kandror
and Pilch, 1994; Martin et al., 1996; Mastick et al., 1994).
This compartment may represent a specialized intracellu-
lar storage depot possibly analogous to small synaptic ves-
icles (Herman et al., 1994; Martin et al., 1996; Verhey et al.,
1995). How is this storage compartment formed and what
is its relationship to other regulated secretory compart-
ments? By examining the location of GLUT-4 in an insulin-
regulated cell type that also contains a bona fide regulated
secretory system we hoped to address these questions.
Using immunoelectron microscopy to localize GLUT-4 in
atrial cardiac myocytes we have found that a substantial
proportion (50-60%) of the total GLUT-4 found in these
cells is targeted to ANF-containing secretory granules with
the remainder localized to the TGR and T-V elements,
similar to those identified in other insulin-sensitive cells
(Slot et al., 1991a,b).
Regulated secretory granules of the type found in atrial
myocytes are synthesized along the biosynthetic route of
the secretory pathway. In the atrial cell secretory granules
at various stages of maturation are readily detected through-
out the Golgi apparatus, in the TGR and scattered through-
out the cytoplasm. GLUT-4 may enter this organelle either
during the course of its own biosynthesis or via recycling,
presumably through the trans-Golgi elements. The earliest
point along the secretory pathway where we could detect Table II. Influence of Insulin on [3H]-2-Deoxyglucose Uptake 
in Heart Regions of 24-h–fasted Rats
Glucose metabolic index (Rg’)
Basal Insulin
mmol/min/100 g
Right atrium 1.5 6 0.1 33 6 5
Left atrium 2.4 6 0.5 46 6 10
Right ventricle 2.2 6 0.3 88 6 7
Left ventricle 2.7 6 0.3 133 6 8
Animals with indwelling catheters in the jugular vein and carotid artery were fasted
for 24 h. Animals were either infused with saline (basal) or insulin and a variable rate
glucose infusion to maintain euglysemia for 75 min. A bolus of [3H]-2-deoxyglucose
was then administered intravenously, and after 45 min tissues were removed and radio-
labeled. 2-Deoxyglucose was quantified by scintillation counting and expressed as a
glucose metabolic index (Rg’) as described previously (Kraegen et al., 1995). Values
represent mean 6 SEM of n 5 8 (basal) and n 5 3 (insulin).
Table III. Effect of Insulin on ANF Secretion 
Time after insulin Serum ANF
min
210 100
10 93.5 6 13.5
40 101.8 6 23.2
70 94.3 6 4.2
Animals with indwelling catheters in the jugular vein and carotid artery were fasted
for 24 h. Animals were infused with insulin and a variable rate glucose infusion to
maintain euglycemia. Blood samples were removed 10 min before commencement of
the insulin infusion and at 10, 40, and 70 min during the infusion. Values represent
mean 6 SEM (n 5 4). All values were expressed as a percentage of the preinsulin
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ANF labeling was in the cis and medial Golgi cisternae. At
this point ANF labeling is usually dispersed or just starting
to aggregate (Fig. 4), presumably representing the early
stages of granule formation, as suggested previously
(Jamieson and Palade, 1964). The membranes around
these forming granules were not labeled for GLUT-4, but
they became GLUT-4 positive at the trans side of the
Golgi stacks and in the TGR. To determine if this was
newly synthesized GLUT-4 accumulating in the TGR we
examined the effects of protein synthesis inhibitors on
GLUT-4 targeting. Cyclohexamide caused a pronounced
inhibition of protein synthesis in atrial myocytes as deter-
mined by the complete disappearance of ANF labeling
throughout the Golgi apparatus. Despite this, GLUT-4
levels in the TGR remained unaffected by this treatment.
It is possible that newly synthesized GLUT-4 is actively re-
tained in the TGR for long periods. However, several ob-
servations indicate that TGR-derived GLUT-4 stems from
the recycling pathway rather than the biosynthetic path-
way: (a) In response to acute insulin treatment in adipo-
cytes and cardiac myocytes (Slot et al., 1991a,b) there is a
significant decline in GLUT-4 levels in the TGR, suggest-
ing that GLUT-4 in the TGR readily exchanges with the
cell surface and presumably endosomes. (b) After expres-
sion of GLUT-4 in fibroblasts using a viral expression sys-
tem we have detected GLUT-4 labeling throughout the
biosynthetic pathway. In response to cyclohexamide treat-
ment for 45 min, GLUT-4 labeling in the ER and Golgi
cisternae of these cells was completely depleted whereas
the level of GLUT-4 in the TGR remained constant (Piper
et al., 1992). (c) Previous studies have shown that cyclo-
hexamide does not alter the localization of other recycling
proteins, such as the asialoglycoprotein receptor and the
mannose 6-phosphate receptor (MPR), in the TGR (Geuze
et al., 1984) consistent with the data reported here for
GLUT-4. Collectively, these findings indicate that GLUT-4
traffics through the TGR and this explains its presence in
this organelle in all of these cell types. Thus, it is most
likely that GLUT-4 enters the ANF granules via this recy-
cling pathway rather than the biosynthetic route.
The recycling of membrane proteins through the TGR is
quite specific as most endosomal proteins appear to avoid
this route. Using resialylation as an index of sorting through
the TGR, Duncan and Kornfeld (1988) showed that both
MPRs are resialylated with a t1/2 of z3 h whereas other cell
surface glycoproteins acquire sialic acid at a 10-fold slower
rate. The most likely explanation for this is that a small
subset of surface glycoproteins cycle through the TGR at a
similar rate to the MPR while the remainder do not cycle
through this compartment at all. This being the case, the
fact that we observe such a large proportion of the total
GLUT-4 complement within secretory granules in myo-
cytes implies that the majority of GLUT-4 probably recy-
cles via the TGR in these cells. Further studies using ap-
proaches similar to that used for the MPRs will be
required to test this hypothesis and to determine if a simi-
lar trafficking pathway is used by GLUT-4 in other insu-
lin-sensitive cell types.
The recycling of GLUT-4 via the TGR may be central to
the unique character of this protein. GLUT-4 has been
shown to have a much slower exocytic rate than other re-
cycling proteins such as the transferrin receptor (for re-
view see James et al., 1994) and this may be in part be-
cause it follows a completely distinct trafficking pathway
through the TGR. Immuno-EM studies taught us that
GLUT-4 is concentrated in the TGR in all insulin-sensi-
tive cells (Slot et al., 1991 a,b; James et al., 1994) consistent
with it possibly being retained in this organelle. Also it is
conceivable that the intracellular GLUT-4 storage depot
(Herman et al., 1994; Martin et al., 1996; Verhey et al.,
1995) may form at the level of the TGR rather than endo-
somes. This may explain the significant colocalization be-
tween GLUT-4 and MPR in insulin-sensitive cell types
(Hanpeter and James, 1995; Martin et al., 1996). In addi-
tion, we have recently shown that there is significant colo-
calization between AP1, the Golgi-specific adaptor pro-
tein, and GLUT-4 in vesicles isolated from adipocytes
(Martin, S., and D. James, unpublished data). Further-
more, insulin stimulates the efflux of a number of TGR re-
cycling proteins as well as constitutive secretory proteins
such as adipsin (for review see Lienhard, 1989). It has
been reported that the TGR-specific protein TGN38 does
not colocalize with GLUT-4 in adipocytes (Martin et al.,
1994). This may reflect the heterogeneous composition of
the TGR as shown recently (Glickman et al., 1996). In our
present study we could not confirm this, being unsuccess-
ful in detecting TGN38 in the sections of the atrial cells.
Despite the targeting of GLUT-4 to the ANF-contain-
ing secretory granules there was also a significant amount
in T-V elements that were morphologically indistinguish-
able from those found in other cell types. Hence, it is likely
that if both organelles bud from the TGR they do so via
different sorting mechanisms. The presence of GLUT-4 in
ANF granules does not appear to reflect a default pathway
in these cells because vp165, which colocalizes with GLUT-4
in adipocytes, is not targeted to the ANF granules in the
atrial cells, but colocalizes there with GLUT-4 in the T-V
elements (Martin et al., 1997). Furthermore, it has been
reported that GLUT-4 but not GLUT-1 is targeted to
secretory granules in PC12 cells (Hudson et al., 1993).
Thus, this implies the presence of a specific sorting signal
in GLUT-4 that targets it for entry into this organelle.
The targeting of GLUT-4 into regulated secretory gran-
ules appears to be cell specific. In PC12 cells or insulinoma
cells transfected with the GLUT-4 cDNA, relatively low
levels (Hudson et al., 1993), or no GLUT-4 (Herman et al.,
1994; Thorens and Roth, 1996), were detected in the secre-
tory compartment. In renal arteriolar cells of the juxta
glomerular apparatus, where GLUT-4 is also expressed
endogenously, there is very little GLUT-4 labeling of the
renin-containing secretory granules, most being found in
T-V elements (Anderson, T.J., S. Martin, D.E. James, J.W.
Slot, J.L. Berka, and J. Stow, manuscript submitted for
publication). However, similar differences have been re-
ported for other secretory proteins. For instance, in the case
of P-selectin, which is very efficiently targeted to a-granules
in platelets (Stenberg et al., 1985), only a small proportion
is found in secretory granules in AtT-20 cells (Koedam
et al., 1992). Such differences likely reflect differences be-
tween individual cell types in GLUT-4 expression, the rate
of granule formation and their average lifetime before se-
cretion, or the rate of GLUT-4 TGR recycling. The atrial
cell is in some respects an atypical secretory cell because
granule formation begins at a very early stage of the bio-Slot et al. GLUT-4 in Atrial Natriuretic Factor Granules 1253
synthetic pathway (Fig. 4, and Rambourg et al., 1984) and
there is not much indication of further maturation of the
granule after its exit from the TGR. For example, many
ANF granules appear to retain the AP1-specific coat in
the atrial myocyte (Fig. 3 C) until secretion (Newman and
Severs, 1992). This is quite different from other endocrine
cells where granules begin to form in the TGR and con-
tinue to mature after budding from the TGR (Arvan and
Castle, 1992; Rindler, 1992; Tooze, 1991), during which
process they tend to lose clathrin coats (Dittié et al., 1996).
Thus, it is possible that GLUT-4 is efficiently targeted to
the regulated secretory pathway in all cases but is trans-
ported out of the secretory granules during their post-
TGR maturation to different extent in individual cell
types. Therefore, the proportion of GLUT-4 that is found
in the secretory granule compartment in a particular cell
will reflect a balance of each of these parameters which in
all likelihood vary considerably from one cell to another.
Does insulin stimulate the movement of GLUT-4 from
ANF-containing secretory granules to the cell surface in
atrial myocytes? Answers to this question may provide in-
sight into the physiological basis for the targeting of GLUT-4
to this organelle, which at present remains unknown. In
theory GLUT-4 could move from the granules to the cell
surface in two ways. First, as the granules fuse with the cell
surface during secretion the granule membrane protein
cargo presumably inserts into the surface membrane.
However, as described above we have been unable to de-
tect an effect of insulin on ANF secretion and therefore
regulation of this route by insulin seems unlikely. The sec-
ond possibility is that small GLUT-4–containing vesicles
may bud from the ANF granules. This would probably re-
sult in GLUT-4 translocation without substantial amounts
of ANF secretion. Such budding via coated vesicles com-
monly occurs from immature secretory granules in other
endocrine cell types. The presence of AP1-positive clath-
rin coats on the ANF granules, with some decreasing fre-
quency during their lifetime (Newman and Severs, 1992),
indicates that there may be a route for GLUT-4 out of the
granules by budding. It remains to be seen if this is regu-
lated by insulin. The insulin effects on GLUT-4 distribu-
tion were too small to measure shifts of GLUT-4 labeling
either from the ANF granules or from other cellular pools
(T-V elements; TGR). Therefore we cannot yet determine
the precise intracellular origin of the GLUT-4 that is
translocated to the cell surface by insulin in this cell. How-
ever, the involvement of the ANF granules via these bud-
ding vesicles would place them functionally in line with the
TGR, as is suggested for the regulated secretory compart-
ment at an immature stage in other cell types (Arvan and
Castle, 1992).
We thank Jenny Stow, Rob Parton, Hans Geuze, and Peter Peters for
helpful discussions and for reading the manuscript, and Russel Wilson for
his contribution to the practical part of this study.
This work was supported by grants from the National Health and Med-
ical Research Council of Australia and the Juvenile Diabetes Foundation
International. D.E. James is a Wellcome Trust Professorial Research Fellow.
Received for publication 16 August 1996 and in revised form 27 March 1997.
References
Arvan, P., and D. Castle. 1992. Protein sorting and secretion granule formation
in regulated secretory cells. Trends Cell Biol. 2:327–331.
Bell, G.I., C.F. Burant, J. Takeda, and G.W. Gould. 1993. Structure and func-
tion of mammalian facilitative sugar transporters. J. Biol. Chem. 268:19161–
19164.
Birnbaum, M.J. 1989. Identification of a novel gene encoding an insulin-respon-
sive glucose transporter protein. Cell 57:305–315.
Cain, C.C., W.S. Trimble, and G.E. Lienhard. 1992. Members of the VAMP
family of synaptic vesicle proteins are components of glucose transporter-
containing vesicles from rat adipocytes. J. Biol. Chem. 267:11681–11684.
Cantin, M., G. Thibault, H. Haile Meskel, M. Ballak, R. Garcia, G. Jasmin, and
J. Genet. 1990. Immuno-electron microscopy of atrial natriuretic factor
secretory pathways in atria and ventricles of control and cardiomyopathic
hamsters with heart failure. Cell Tissue Res. 261:313–322.
Cushman, S.W., and L.J. Wardzala. 1980. Potential mechanism of insulin action
on glucose transport in the isolated rat adipose cell: apparent translocation
of intracellular transport systems to the plasma membrane. J. Biol. Chem.
255:4758–4762.
De Bold, A.J. 1985. Atrial natriuretic factor: a hormone produced by the heart.
Science (Wash. DC). 230:767–770.
Dittié, A.S., N. Hajibagheri, and S.A. Tooze. 1996. The AP-1 adaptor complex
binds to immature secretory granules from PC12 cells, and is regulated by
ADP-ribosylation factor. J. Cell Biol. 132:523–536.
Duncan, J.R., and S. Kornfeld. 1988. Intracellular movement of two mannose
6-phosphate receptors: return to the Golgi apparatus. J. Cell Biol. 106:617–628.
Geuze, H.J., J.W. Slot, G.J. Strous, J.P. Luzio, and A.L. Schwartz. 1984. A cy-
clohexamide-resistant pool of receptors for asialoglycoproteins and man-
nose 6-phosphate residues in the Golgi complex of hepatocytes. EMBO
(Eur. Mol. Biol. Organ.) J. 3:2677–2685.
Glickman, J.M., P.A. Morton, J.W. Slot, S. Kornfeld, and H.J. Geuze. 1996. The
biogenesis of the MHC class II compartment in human I-cell disease B lym-
phocytes. J. Cell Biol. 132:769–785.
Griffiths, G., and K. Simons. 1986. The trans Golgi network: sorting at the exit
site of the Golgi complex. Science (Wash. DC). 234:438–443.
Hanpeter, D., and D.E. James. 1995. Characterisation of the intracellular
GLUT-4 compartment. Mol. Membr. Biol. 12:263–269.
Herman, G.A., F. Bonzelius, A-M. Cieutat, and R.B. Kelly. 1994. A distinct
class of intracellular storage vesicles, identified by expression of the glucose
transporter GLUT-4. Proc. Natl. Acad. Sci. USA. 91:12750–12754.
Horky, K., J. Gutkowska, J. Garcia, G. Thibault, J. Genest, and M. Cantin.
1985. Effect of different anesthetics on immunoreactive atrial natriuretic fac-
tor concentrations in rat plasma. Biochem. Biophys. Res. Commun. 129:651–657.
Hudson, A.W., D.C. Fingar, G.A. Seidner, G. Griffiths, B. Burke, and M.J.
Birnbaum. 1993. Targeting of the insulin-responsive glucose transporter
(GLUT-4) to the regulated secretory pathway in PC12 cells. J. Cell Biol. 122:
579–588.
Itoh, H., K. Nakao, A. Sugawara, Y. Saito, M. Mukoyama, N. Morii, T. Ya-
mada, S. Shiono, H. Arai, K. Hosoda, and H. Imura. 1988. g-atrial natri-
uretic polypeptide (gANP)-derived peptides in human plasma: cosecretion
of N-terminal gANP fragment and aANP. J. Clin. Endocrinol. Metab. 67:
429–437.
James, D.E., and R.C. Piper. 1994. Insulin resistance, diabetes, and the insulin-
regulated trafficking of GLUT-4. J. Cell Biol. 126:1123–1126.
James, D.E., M. Strube, and M. Mueckler. 1989. Molecular cloning and charac-
terisation of an insulin regulatable glucose transporter. Nature (Lond.). 338:
83–87.
James, D.E., R.C. Piper, and J.W. Slot. 1994. Insulin stimulation of GLUT-4
translocation: a model for regulated recycling. Trends Cell Biol. 4:120–126.
Jamieson, J.D., and G.E. Palade. 1964. Specific granules in atrial muscle cells. J.
Cell Biol. 25:151–172.
Kandror, K.V., and P.F. Pilch. 1994. gp160, a tissue-specific marker for insulin-
activated glucose transport. Proc. Natl. Acad. Sci. USA. 91:8017–8021.
Koedam, J.A., E.M. Cramer, E. Briend, B. Furie, B.C. Furie, and D.D. Wagner
1992. P-selectin, a granule membrane protein of platelets and endothelial
cells, follows the regulated secretory pathway in AtT-20 cells. J. Cell Biol.
116:617–625.
Kraegen, E.W., D.E. James, A.B. Jenkins, and D.J. Chisholm. 1985. Dose-
response curves for in vivo insulin sensitivity in individual tissues in rats.
Am. J. Physiol. 248: E353–E362.
Lang, R.E., H. Tholken, D. Ganten, F.C. Luft, H. Ruskoaho, and T. Unger.
1985. Atrial natriuretic factor-a circulating hormone stimulated by volume
loading. Nature (Lond.). 314:264–266.
Lienhard, G. 1989. Insulin may cause translocation of proteins to the cell sur-
face by stimulating membrane trafficking from the trans Golgi reticulum. In
Genes and Gene Products in the Development of Diabetes Mellitus. J.
Nerup, T. Mandrup-Poulson, and B. Hokfelt, editors. Elsevier Science Pub-
lishing Co., Inc., New York. 313–328.
Liou, W., H.J. Geuze, and J.W. Slot. 1996. Improving structural integrity of cryo-
sections for immunogold labeling. Histochem. Cell Biol. 106:41–58.
Livingstone, C., D.E. James, J.E. Rice, D. Hanpeter, and G.W. Gould. 1996.
Compartment ablation analysis of the insulin-responsive glucose transporter
(GLUT-4) in 3T3-L1 adipocytes. Biochem. J. 315:487–495.
Manning, P.T., D. Schwartz, N.C. Katsube, S.W. Holmberg, and P. Needleman.
1985. Vasopressin-stimulated release of atriopetin: endocrine antagonists in
fluid homeostasis. Science (Wash. DC). 229:395–397.
Martin, S., B. Reaves, G. Banting, and G.W. Gould. 1994. Analysis of the co-The Journal of Cell Biology, Volume 137, 1997 1254
localisation of the insulin-responsive glucose transporter (GLUT-4) and the
trans Golgi network marker TGN38 within 3T3-L1 adipocytes. Biochem. J.
300:743–749.
Martin, S., J. Tellam, C. Livingstone, J.W. Slot, G.W. Gould, and D.E. James.
1996. The glucose transporter (GLUT-4) and vesicle-associated membrane
protein-2 (VAMP-2) are segregated from recycling endosomes in insulin-
sensitive cells. J. Cell Biol. 134:625–635.
Martin, S., J.E. Rice, G.W. Gould, S.R. Keller, J.W. Slot, and D.E. James. 1997.
The glucose transporter GLUT4 and the aminopeptide vp165 colocalise in
tubulo-vesicular elements in adipocytes and cardiomyocytes. J. Cell Sci. In
press.
Mastick, C.C., R. Aebersold, and G.E. Lienhard. 1994. Characterisation of a
major protein in GLUT-4 vesicles. J. Biol. Chem. 269:6089–6092.
Newman, T.M., and N.J. Severs. 1992. Coated vesicles are implicated in the
post-fusion retrieval of the membrane of rat atrial secretory granules. Cell
Tissue Res. 268:463–469.
Piper, R.C., C. Tai, J.W. Slot, C.S. Hahn, C.M. Rice, H. Huang, and D.E. James.
1992. The efficient intracellular sequestration of the insulin-regulatable glu-
cose transporter (GLUT-4) is conferred by the NH2 terminus. J. Cell Biol.
117:729–743.
Rambourg, A., D. Segretain, and Y. Clermont. 1984. Tridimensional architec-
ture of the Golgi apparatus in the atrial muscle cell of the rat. Am. J. Anat.
170:163–179.
Rindler, M.J. 1992. Biogenesis of storage granules and vesicles. Curr. Opin. Cell
Biol. 4:616–622.
Robinson, L.J., S. Pang, D.S. Harris, J. Heuser, and D.E. James. 1992. Translo-
cation of the glucose transporter (GLUT-4) to the cell surface in permeabi-
lized 3T3-L1 adipocytes: effects of ATP, insulin and GTPgS and localization
of GLUT-4 to clathrin lattices. J. Cell Biol. 117:1181–1196.
Rodnick, K.J., J.W. Slot, D.R. Studelska, D.E. Hanpeter, L.J. Robinson, H.J.
Geuze, and D.E. James. 1992. Immunocytochemical and biochemical studies
of GLUT-4 in rat skeletal muscle. J. Biol. Chem. 267:6278–6285.
Ruskoaho, H. 1992. Atrial natriuretic peptide: synthesis, release and metabo-
lism. Pharmacol. Rev. 44:479–602.
Roth, J., M. Bendayan, and L. Orci. 1978. Ultrastructural localization of intra-
cellular antigens by the use of protein A-gold complex. J. Histochem. Cy-
tochem. 26:1074–1081.
Slot, J.W., and H.J. Geuze. 1985. A new method of preparing gold probes for
multiple labeling cytochemistry. Eur. J. Cell Biol. 38:87–93.
Slot, J.W., H.J. Geuze, and A.H. Weerkamp. 1988. Localization of macromo-
lecular components by application of the immunogold technique on cryosec-
tioned bacteria. Methods Microbiol. 20:211–236.
Slot, J.W., H.J. Geuze, S. Gigengack, G.E. Lienhard, and D.E. James. 1991a.
Immunolocalization of the insulin-regulatable glucose transporter in brown
adipose tissue of the rat. J. Cell Biol. 113:123–135.
Slot, J.W., H.J. Geuze, S. Gigengack, D.E. James, and G.E. Lienhard. 1991b.
Translocation of the glucose transporter GLUT-4 in cardiac myocytes of the
rat. Proc. Natl. Acad. Sci. USA. 88:7815–7819.
Stenberg, P.E., R.P. McEver, M.A. Schuman, Y.V. Jaques, and D.F. Bainton.
1985. A platelet alpha-granule membrane protein (GMP-140) is expressed
on the plasma membrane after activation. J. Cell Biol. 101:880–886.
Suzuki, K., and T. Kono. 1980. Evidence that insulin causes the translocation of
glucose transport activity to the plasma membrane from an intracellular
storage site. Proc. Natl. Acad. Sci. USA. 77:2542–2545.
Thibault, G., K.K. Murthy, J. Gutkowska, N.G. Seidah, C. Lazure, M. Chretien,
and M. Cantin. 1988. NH2-terminal fragment of rat pro-atrial natriuretic fac-
tor in the circulation: identification, radioimmunoassay and half-life. Pep-
tides. 9:47–53.
Thibault, G., H. Haile-Meskel, E. Wrobel-Conrad, M. Ballak, R. Garcia, J.
Genest, and M. Cantin. 1989. Processing of the natriuretic factor propeptide
by atrial cardiocytes as revealed by immunocryoultramicrotomy. Endo-
crinology. 124:3109–3116.
Thorens, B., and J. Roth. 1996. Intracellular targeting of GLUT-4 in transfected
insulinoma cells: evidence for association with constitutively recycling vesi-
cles distinct from synaptophysin and insulin vesicles. J. Cell Science. 109:
1311–1323.
Tooze, S.A. 1991. Biogenesis of secretory granules. Implications arising from
the immature secretory granule in the regulated pathway of secretion. FEBS
(Fed. Eur. Biochem. Soc.) Lett. 285:220–224.
Verhey, K.J., J.-I. Yeh, and M.J. Birnbaum. 1995. Distinct signals in the GLUT-4
glucose transporter for internalization and for targeting to an insulin-respon-
sive compartment. J. Cell Biol. 130:1071–1079.